Inventor · disambiguated record
Christopher Charles Stimson
Also filed as: STIMSON CHRISTOPHER · STIMSON CHRISTOPHER CHARLES
6 granted patents·6 pending applications·3 citations·filing 2010–2023
69Inventor score
Top patents by PatentIndex Score
12 records- 0180US11364246B2CompoundsTMEM16A LTD·Filed 2019·Granted Jun 21, 2022·2 cites·11 claims
- 0272US11905270B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2017·Granted Feb 20, 2024·1 cites·3 claims
- 0368US12239630B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2023·Granted Mar 4, 2025·0 cites·3 claims
- 0466US12023319B2Carboxylic acid aromatic amidesBayer Pharma AG·Filed 2021·Granted Jul 2, 2024·0 cites·5 claims
- 0561US12377105B2CompoundsTMEM16A LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 0649US2022235006A1Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditionsTMEM16A LTD·Filed 2022·Application pending·0 cites
- 0743US2020361871A1CompoundsENTPR THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0840US2019177279A1Carboxylic acid aromatic 1,2-cyclopropylamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 0940US2019194148A1Tetrazole-containing 1,2-cyclopropane-carboxamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 1040US2019177284A1Tetrazolyl-containing cyclopropanecarboxamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 1138US2021317092A1Tetrazole containing compoundsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1226US8912176B2Azetidines as histamine H3 receptor antagonistsDAVENPORT ADAM JAMES·Filed 2010·Granted Dec 16, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Charles Stimson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →